67 related articles for article (PubMed ID: 575495)
1. Protective action of creatinol O-phosphate against serum CPK activity enhanced by isoprenaline in the rat.
Marzo A; Ghirardi P
Arzneimittelforschung; 1979; 29(9a):1471-3. PubMed ID: 575495
[TBL] [Abstract][Full Text] [Related]
2. An analysis of the reduction by creatinol O-phosphate of the myocardial lesions evoked by isoprenaline in the rat.
Godfraind T; Sturbois X
Arzneimittelforschung; 1979; 29(9a):1457-64. PubMed ID: 575492
[TBL] [Abstract][Full Text] [Related]
3. Ionic changes evoked by isoprenaline in rat hearts in vivo and in vitro and their reduction by creatinol O-phosphate.
Godfraind T; Ghysel-Burton J; Sturbois X
Arzneimittelforschung; 1979; 29(9a):1468-70. PubMed ID: 575494
[TBL] [Abstract][Full Text] [Related]
4. The action of creatinol 0-phosphate on the inotropic effect of isoprenaline in isolated rat atria and in anesthetized dogs.
Godfraind T; Ghysel-Burton J; Merlo L
Arzneimittelforschung; 1979; 29(9a):1465-7. PubMed ID: 575493
[TBL] [Abstract][Full Text] [Related]
5. Action of creatinol-O-phosphate on the contractility changes evoked by hypoxia and ischemia in rat isolated heart.
Godfraind T; Saleh MM
Arzneimittelforschung; 1984; 34(9):968-72. PubMed ID: 6542374
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of creatinol O-phosphate (COP) on ventricular fibrillation and death induced by intravenous CaCl2 in mice.
Ferrini R; Miragoli G
Arzneimittelforschung; 1979; 29(9a):1473-4. PubMed ID: 575496
[TBL] [Abstract][Full Text] [Related]
7. Effects of creatinol O-phosphate on serum enzymes in acute myocardial infarction.
Knippel M; Bana G; Pusterla GL
Arzneimittelforschung; 1979; 29(9a):1480-2. PubMed ID: 575498
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological and toxicological properties of creatinol O-phosphate. A review.
Marzo A; Ghirardi P
Arzneimittelforschung; 1979; 29(9a):1449-52. PubMed ID: 395957
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of creatinol O-phosphate (COP) on some experimental arrhythmias in vitro and in vivo.
Ferrini R; Miragoli G
Arzneimittelforschung; 1979; 29(9a):1475-7. PubMed ID: 575497
[TBL] [Abstract][Full Text] [Related]
10. Preliminary report on electrophysiological effectiveness of creatinol O-phosphate (COP) in human subjects.
Botti G; Bonatti V
Arzneimittelforschung; 1979; 29(9a):1491-4. PubMed ID: 575499
[TBL] [Abstract][Full Text] [Related]
11. Acute clinical tolerance of creatinol O-phosphate.
Melloni GF; Minoja GM; Lureti GF; Merlo L; Pamparana F; Brusoni B
Arzneimittelforschung; 1979; 29(9a):1447-9. PubMed ID: 575490
[TBL] [Abstract][Full Text] [Related]
12. The prevention by creatinol O-phosphate of myocardial lesions evoked by isoprenaline.
Godfraind T; Sturbois X
Arch Int Pharmacodyn Ther; 1979 Feb; 237(2):288-97. PubMed ID: 573603
[TBL] [Abstract][Full Text] [Related]
13. Activity of creatinol O-phosphate on persistent ventricular premature beats in ischemic heart disease. Double blind clinical trial.
Di Maio F; Neri A; Soccorsi P; Sciacca A
Arzneimittelforschung; 1979; 29(9a):1488-90. PubMed ID: 395959
[TBL] [Abstract][Full Text] [Related]
14. Oxyfedrine and propranolol. A comparative experimental approach to protect myocardium against isoprenaline-induced myocardial necrosis.
Seth SD; Gupta MP; Gupta M; Manchanda SC
Arzneimittelforschung; 1984; 34(6):678-83. PubMed ID: 6541488
[TBL] [Abstract][Full Text] [Related]
15. Antiarrhythmic effectiveness of creatinol O-phosphate in man.
Cadel A; Palumbo A; Zerilli G; Pria R; Fanciulli R; Conversano S; Galbiati R
Arzneimittelforschung; 1979; 29(9a):1485-7. PubMed ID: 94266
[TBL] [Abstract][Full Text] [Related]
16. [Effects of creatinol O-phosphate on the isolated rabbit's atrium and on the rat's phrenic nerve diaphragm preparation].
Ferrini R; Miragoli G
Farmaco Sci; 1975 Nov; 30(11):912-6. PubMed ID: 1238289
[TBL] [Abstract][Full Text] [Related]
17. Role of free fatty acids in catecholamine-induced cardiac necrosis.
Kjekshus JK
Recent Adv Stud Cardiac Struct Metab; 1975; 6():183-91. PubMed ID: 1197880
[TBL] [Abstract][Full Text] [Related]
18. Creatinol O-phosphate therapy in patients with inadequate coronary circulation. Double-blind clinical trial.
Barlattani M; Guglielmi G; Mammarella A
Arzneimittelforschung; 1979; 29(9a):1483-5. PubMed ID: 395958
[TBL] [Abstract][Full Text] [Related]
19. [Protection of oxyphenamone against cardiac arrest-reperfusion injury of isolated rat hearts].
Fan LL; Li H; Fan MJ; Zhang RD
Yao Xue Xue Bao; 2005 Aug; 40(8):705-10. PubMed ID: 16268504
[TBL] [Abstract][Full Text] [Related]
20. Effects of creatinol-O-phosphate (COP) on haemodynamics and cardiac metabolism in conscious and anaesthetized dogs.
Marchetti G; Merlo L
Arzneimittelforschung; 1978; 28(10):1708-11. PubMed ID: 582673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
